tiprankstipranks
Trending News
More News >

Farzan Nima Insider Profile

4 Followers
Farzan Nima, Director at Keros Therapeutics, holds 5.25K shares in Keros Therapeutics (Ticker: KROS), holds 0.00 shares in Kinnate Biopharma (Ticker: KNTE).
tipranks
Farzan Nima

Farzan Nima
Keros Therapeutics (KROS)
Director

Not Ranked
Farzan Nima has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$84K
100.00%
A breakdown of Farzan Nima's holdings

Insider Roles

Keros Therapeutics
(KROS)
Director
Roles that Farzan Nima holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Farzan Nima

Farzan Nima's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Keros Therapeutics
Jun 06, 2025
Director
Uninformative Buy
$84.21K
KNTE
Kinnate Biopharma
Apr 05, 2024
Uninformative Sell
$0.00
List of latest transactions for each holding click on a transaction to see Farzan Nima's performance on stock

Farzan Nima insider profile FAQ

What is the percentage of profitable transactions made by Farzan Nima?
The percentage of profitable transactions made by Farzan Nima is ―.
    What is the average return per transaction made by Farzan Nima?
    The average return per transaction made by Farzan Nima is ―.
      What stocks does Farzan Nima hold?
      Farzan Nima holds: KROS, KNTE stocks.
        What was Farzan Nima’s latest transaction?
        Farzan Nima latest transaction was an Uninformative Buy of ―.
          What was Farzan Nima's most profitable transaction?
          Farzan Nima’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Farzan Nima's role in Keros Therapeutics?
            Farzan Nima's role in Keros Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.